Correvio Pharma (CORV) Tops Q1 EPS by 31c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. BAC
4. UNH
5. ORCL
6. AVAV
7. META
8. VSTM
9. GS
10. DVLT

Go back to Correvio Pharma (CORV) Tops Q1 EPS by 31c, Revenues Miss

Correvio Reports Second Quarter 2018 Financial Results

August 14, 2018 4:00 PM EDT

Management to Host Conference Call and Webcast Today, August 14, 2018 at 4:30 p.m. Eastern (1:30 p.m. Pacific)

NASDAQ: CORV  TSX: CORV

VANCOUVER, Aug. 14, 2018 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today reported financial results for its second quarter ended June 30, 2018 and commented on recent accomplishments and plans.

"The first half of 2018 was marked by several important achievements, including the confirmed ability to resubmit the Brinavess® (vernakalant... More